Unique Ligand Binding Sites on CXCR4 Probed by a Chemical Biology Approach: Implications for the Design of Selective Human Immunodeficiency Virus Type 1 Inhibitors
Won‐Tak Choi(University of California, San Francisco), Ziwei Huang(Stomatology Hospital), Navid Madani(Harvard University), Joseph Sodroski(Harvard University), Dongxiang Liu(Thomas Jefferson University), Santosh Kumar, Shaomin Tian(University of North Carolina at Chapel Hill), Jing An(University of California San Diego), Chang‐Zhi Dong(University of Illinois Urbana-Champaign)
Cited by 71
Related Papers
Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias
|Molecular Cancer Therapeutics|2006|186
Structural and Functional Characterization of Human CXCR4 as a Chemokine Receptor and HIV-1 Co-receptor by Mutagenesis and Molecular Modeling Studies
|Journal of Biological Chemistry|2001|138
Bio-template synthesis of Mo-doped polymer carbon nitride for photocatalytic hydrogen evolution
|Applied Catalysis B: Environmental|2019|133
Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis
|Frontiers in Oncology|2021|125